CBNPC et personnes âgées: Quelle chimiothérapie ?
作者： E. Quoix
DOI: 10.1016/S0761-8425(06)72055-1
关键词:
摘要: Resume Le cancer bronchique atteint une fois sur deux un patient de plus 65 ans et trois 70 ans. L’augmentation l’incidence avec l’âge l’allongement la duree vie dans population expliquent le nombre important des cancers bronchiques diagnostiques chez les personnes âgees. Leur prise en charge correcte se heurte a plusieurs obstacles : certain nihilisme patients medecins, l’idee fausse que progresse moins vite âgees enfin quasi-absence d’essais therapeutiques dedies aux sujets âges. Cette situation est train d’evoluer enquetes meme essais mis œuvre specifiquement aupres devraient permettre mieux adapter traitement l’âge, mais surtout comorbidites, sans etre pour autant suboptimal.
sci-hub.se 参考文章(34)
J. Piquet, F. Blanchon, M. Grivaux, T. Collon, M. Zureik, H. Barbieux, M. Bénichou-Flurin, J.-L. Breton, D. Coëtmeur, B. Delclaux, D. Braun, J.-P. Homasson, F. Mouysset, R. Riou, M. Le Poulain-Doubliez, L. Marsal, Le cancer bronchique primitif du sujet âgé en France Revue Des Maladies Respiratoires. ,vol. 21, pp. 70- 78 ,(2004) , 10.1016/S0761-8425(04)71564-8
Gianfranco Buccheri, Domenico Ferrigno, Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a phase II study. Cancer. ,vol. 88, pp. 2677- 2685 ,(2000) , 10.1002/1097-0142(20000615)88:12<2677::AID-CNCR5>3.0.CO;2-B
John D. Hainsworth, Howard A. Burris, Sharlene Litchy, Lisa H. Morrissey, John H. Barton, James E. Bradof, F. Anthony Greco, Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial. Cancer. ,vol. 89, pp. 328- 333 ,(2000) , 10.1002/1097-0142(20000715)89:2<328::AID-CNCR17>3.0.CO;2-F
Giuseppe De Cataldis, Annunziato Iannelli, Domenico Bilancia, Mario Belli, Bruno Massidda, Francovito Piantedosi, Giuseppe Comella, Mario De Lena, Giuseppe Frasci, Vito Lorusso, Nicola Panza, Pasquale Comella, Gianpaolo Nicolella, Andrea Bianco, Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 18, pp. 2529- 2536 ,(2000) , 10.1200/JCO.2000.18.13.2529
K S Albain, J J Crowley, M LeBlanc, R B Livingston, Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. Journal of Clinical Oncology. ,vol. 9, pp. 1618- 1626 ,(1991) , 10.1200/JCO.1991.9.9.1618
Katsuyuki Hotta, Hiroshi Ueoka, Katsuyuki Kiura, Masahiro Tabata, Mitsune Tanimoto, An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer. Lung Cancer. ,vol. 46, pp. 61- 76 ,(2004) , 10.1016/J.LUNGCAN.2004.02.018
Aminah Jatoi, Philip J. Stella, Shauna Hillman, James A. Mailliard, Stephanie Vanone, Edith A. Perez, Michael W. Cannon, Susan Geyer, Martin Wiesenfeld, James R. Jett, Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (≥65 years of age): A phase II North Central Cancer Treatment Group study American Journal of Clinical Oncology. ,vol. 26, pp. 441- 447 ,(2003) , 10.1097/01.COC.0000027460.53907.38
BERNARD S. LINN, MARGARET W. LINN, LEE GUREL, CUMULATIVE ILLNESS RATING SCALE Journal of the American Geriatrics Society. ,vol. 16, pp. 622- 626 ,(1968) , 10.1111/J.1532-5415.1968.TB02103.X
Selim Firat, Roger W Byhardt, Elizabeth Gore, Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies International Journal of Radiation Oncology Biology Physics. ,vol. 54, pp. 357- 364 ,(2002) , 10.1016/S0360-3016(02)02939-5
Karl-Matthias Deppermann, Influence of age and comorbidities on the chemotherapeutic management of lung cancer Lung Cancer. ,vol. 33, pp. S115- S120 ,(2001) , 10.1016/S0169-5002(01)00311-7